From Big Pharma To VC: The Road Travelled By Third Rock’s David Kaufman

 
• By Lucie Ellis-Taitt

VC Playbook: Partner at Third Rock Ventures, David Kaufman, talks to In Vivo about the venture capital firm’s company creation strategy and seeking ‘white space’ in biopharma for innovation. 

mixed pathways
• Source: Alamy

More from C-Suite Speaks

More from Leadership